tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Holding KROS?
Track your performance easily

Keros Therapeutics (KROS) Technical Analysis

308 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Keros Therapeutics’s (KROS) Moving Averages Convergence Divergence (MACD) indicator is -5.58, suggesting Keros Therapeutics is a Sell.
Keros Therapeutics’s (KROS) 20-Day exponential moving average is 15.33, while Keros Therapeutics’s (KROS) share price is $11.31, making it a Sell.
Keros Therapeutics’s (KROS) 50-Day exponential moving average is 27.85, while Keros Therapeutics’s (KROS) share price is $11.31, making it a Sell.

Keros Therapeutics (KROS) Pivot Points

Jan 29, 2025, 05:42 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.66
11.04
11.24
11.62
11.82
12.20
12.40
Fibonacci
11.04
11.26
11.40
11.62
11.84
11.98
12.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Keros Therapeutics (KROS) Moving Averages

Jan 29, 2025, 05:42 PM
Period
Simple
Exponential
MA5
11.60Sell
11.52Sell
MA10
11.37Sell
12.06Sell
MA20
13.37Sell
15.33Sell
MA50
32.98Sell
27.85Sell
MA100
45.99Sell
38.27Sell
MA200
47.92Sell
45.45Sell
Keros Therapeutics’s (KROS) 10-Day exponential moving average is 12.06, while Keros Therapeutics’s (KROS) share price is $11.31, making it a Sell.
Keros Therapeutics’s (KROS) 100-Day exponential moving average is 38.27, while Keros Therapeutics’s (KROS) share price is $11.31, making it a Sell.
Keros Therapeutics’s (KROS) stock price is $11.31 and Keros Therapeutics’s (KROS) 50-day simple moving average is 32.98, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $11.31 and Keros Therapeutics’s (KROS) 100-day simple moving average is 45.99, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $11.31 and Keros Therapeutics’s (KROS) 200-day simple moving average is 47.92, creating a Sell signal.

Keros Therapeutics (KROS) Technical Indicators

Jan 29, 2025, 05:42 PM
Name
Value
Implied Action
RSI (14)
24.04
Buy
STOCH (9,6)
51.41
Neutral
STOCHRSI (14)
26.13
Neutral
MACD (12,26)
-5.58
Sell
ADX (14)
49.97
Neutral
Williams %R
-77.14
Buy
CCI (14)
-68.03
Neutral
ATR (14)
1.65
-
Ultimate Oscillator
42.81
Neutral
ROC
-27.69
Sell
Keros Therapeutics’s (KROS) Relative Strength Index (RSI) is 24.04, creating a Buy signal.
Keros Therapeutics’s (KROS) Trend Strength Indicator (ADX) is 49.97, creating a Neutral signal.
Keros Therapeutics’s (KROS) Commodity Channel Index (CCI) is -68.03, creating a Neutral signal.
Keros Therapeutics’s (KROS) Price Rate of Change (ROC) is -27.69, creating a Sell signal.

FAQ

Is KROS a Buy, Hold, or Sell?
Based on KROS’s technical indicators, KROS is a Strong Sell.
    What is KROS’s RSI (14)?
    KROS’s RSI (14) is 24.04, which suggests KROS is a Buy.
      What is KROS’s MACD?
      KROS’s MACD is -5.58, which suggests KROS is a Sell.
        What is KROS’s 5-day moving average?
        KROS’s 5-day moving average is 11.60, which suggests KROS is a Sell.
          What is KROS’s 20-day moving average?
          KROS 20-day moving average is 13.37, which suggests KROS is a Sell.
            What is KROS’s 50-day moving average?
            KROS’s 50-day moving average is 32.98, which suggests KROS is a Sell.
              What is KROS’s 200-day moving average?
              KROS’s 200-day moving average is 47.92, which suggests KROS is a Sell.
                What is KROS’s Williams % R (14)?
                KROS’s Williams % R (14) is -77.14, which suggests KROS is a Buy.
                  What is KROS’s CCI (14)?
                  KROS’s CCI (14) is -68.03, which suggests KROS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis